On February 21 and March 14, Skadden held a webinar titled “The HHS Drug Discount and Rebate Proposals: What Pharma Companies Need to Know,” which reviewed the Department of Health and Human Services’ (HHS) much-anticipated proposal to reform the anti-kickback safe harbor for drug discounts and rebates. Skadden attorneys analyzed the proposed rule and discussed the potential impact for drugmakers and other industry participants. Partners John Bentivoglio and Maya Florence spoke.
Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates